Systematic review and meta-analysis of studies reporting potency rates after robot-assisted radical prostatectomy.
Standard
Systematic review and meta-analysis of studies reporting potency rates after robot-assisted radical prostatectomy. / Ficarra, Vincenzo; Novara, Giacomo; Ahlering, Thomas E; Costello, Anthony; Eastham, James A; Graefen, Markus; Guazzoni, Giorgio; Menon, Mani; Mottrie, Alexandre; Patel, Vipul R; Henk, Van der Poel; Rosen, Raymond C; Tewari, Ashutosh K; Wilson, Timothy G; Zattoni, Filiberto; Montorsi, Francesco.
In: EUR UROL, Vol. 62, No. 3, 3, 2012, p. 418-430.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Systematic review and meta-analysis of studies reporting potency rates after robot-assisted radical prostatectomy.
AU - Ficarra, Vincenzo
AU - Novara, Giacomo
AU - Ahlering, Thomas E
AU - Costello, Anthony
AU - Eastham, James A
AU - Graefen, Markus
AU - Guazzoni, Giorgio
AU - Menon, Mani
AU - Mottrie, Alexandre
AU - Patel, Vipul R
AU - Henk, Van der Poel
AU - Rosen, Raymond C
AU - Tewari, Ashutosh K
AU - Wilson, Timothy G
AU - Zattoni, Filiberto
AU - Montorsi, Francesco
PY - 2012
Y1 - 2012
N2 - Although the initial robot-assisted radical prostatectomy (RARP) series showed 12-mo potency rates ranging from 70% to 80%, the few available comparative studies did not permit any definitive conclusion about the superiority of this technique when compared with retropubic radical prostatectomy (RRP) and laparoscopic radical prostatectomy (LRP).
AB - Although the initial robot-assisted radical prostatectomy (RARP) series showed 12-mo potency rates ranging from 70% to 80%, the few available comparative studies did not permit any definitive conclusion about the superiority of this technique when compared with retropubic radical prostatectomy (RRP) and laparoscopic radical prostatectomy (LRP).
KW - Humans
KW - Male
KW - Risk Factors
KW - Treatment Outcome
KW - Risk Assessment
KW - Time Factors
KW - Odds Ratio
KW - Evidence-Based Medicine
KW - Recovery of Function
KW - Prostatic Neoplasms/surgery
KW - Robotics
KW - Laparoscopy/adverse effects
KW - Prostatectomy/adverse effects/methods
KW - Surgery, Computer-Assisted/adverse effects
KW - Erectile Dysfunction/etiology/physiopathology
KW - Penile Erection
KW - Humans
KW - Male
KW - Risk Factors
KW - Treatment Outcome
KW - Risk Assessment
KW - Time Factors
KW - Odds Ratio
KW - Evidence-Based Medicine
KW - Recovery of Function
KW - Prostatic Neoplasms/surgery
KW - Robotics
KW - Laparoscopy/adverse effects
KW - Prostatectomy/adverse effects/methods
KW - Surgery, Computer-Assisted/adverse effects
KW - Erectile Dysfunction/etiology/physiopathology
KW - Penile Erection
M3 - SCORING: Journal article
VL - 62
SP - 418
EP - 430
JO - EUR UROL
JF - EUR UROL
SN - 0302-2838
IS - 3
M1 - 3
ER -